Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Pulmonary Pharmacology & Therapeutics|June 25, 2013
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodesRossella Ricci, Candida Palmero, Gyada Bazurro, et al.
Pediatric Transplantation|March 30, 2010
HHV-8-related visceral Kaposi's sarcoma following allogeneic HSCT: report of a pediatric case and literature reviewIlaria Sala, Maura Faraci, Gian M Magnano, et al.
Journal of Neurosurgical Sciences|October 28, 2016
Moyamoya vasculopathy shows a genetic mutational gradient decreasing from East to WestAlessandro Raso, Roberto Biassoni, Samantha Mascelli, et al.
Scientific Reports|July 12, 2023
Gut-microbiota in children and adolescents with obesity: inferred functional analysis and machine-learning algorithms to classify microorganismsMargherita Squillario, Carola Bonaretti, Alberto La Valle, et al.
Microorganisms|August 28, 2025
Predictive Microbial Markers Distinguish Responders and Non-Responders to Adalimumab: A Step Toward Precision Medicine in Ulcerative ColitisShaghayegh Baradaran Ghavami, Arfa Moshiri, Carola Bonaretti, et al.
Neurology. Clinical Practice|November 16, 2022
Pediatric SARS-CoV-2-Related Diplopia and Mesencephalic AbnormalitiesSara Signa, Noemi Brolatti, Chiara Trincianti, et al.
Journal of Virological Methods|September 10, 2011
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2Francesca Gatto, Giulia Cassina, Francesco Broccolo, et al.
International Immunology|January 17, 2009
NKp44 expression, phylogenesis and function in non-human primate NK cellsAndrea De Maria, Elisabetta Ugolotti, Erik Rutjens, et al.
British Journal of Clinical Pharmacology|February 14, 2018
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndromeAlice Bonanni, Marta Calatroni, Matteo D'Alessandro, et al.
Scientific Reports|February 18, 2017
Activating Killer Immunoglobulin Receptors and HLA-C: a successful combination providing HIV-1 controlMauro S Malnati, Elisabetta Ugolotti, Maria Cristina Monti, et al.
Pageof 4